52 in 52 – #9: The COCA Trial

Welcome back to the “52 in 52” series. This collection of posts features recently published must-know articles. Our ninth post looks at the COCA trial.


Author: Brannon Inman (Chief Resident, Emergency Medicine Physician, San Antonio, TX) // Reviewed by: Alex Koyfman, MD (@EMHighAK); Brit Long, MD (@long_brit)


Effect of Intravenous or Intraosseous Calcium vs Saline on Return of Spontaneous Circulation in Adults With Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial

AKA:  THE “COCA” TRIAL

 

Clinical question:

In patients with out-of-hospital cardiac arrest, does the administration of calcium lead to more ROSC?

 

Study design:

  • Double blind, parallel group, superiority, randomized placebo-controlled trial

 

PICO:

Population:

  • Included patients > 18 years in Denmark with out of hospital cardiac arrest
  • Must have received 1 mg epinephrine
  • Exclusion
    • Traumatic cardiac arrest
    • Known or suspected pregnancy
    • Prior enrollment in the trial
    • Receipt of epinephrine outside the trial (i.e. from an EMS not participating in the trial)
    • Clinical indication for calcium (hypocalcemia or hyperkalemia)
  • 391 patients included in analysis, mean age 68 years, male 71%/female 29%, 75% with initial nonshockable rhythm, 82% cardiac arrest at home

 

Intervention:

  • Calcium IV or IO x 2 doses (5 mmol or 200 mg of calcium chloride), first dose administered right after first dose of epinephrine
  • Median time to study drug administration of 18 minutes
  • IO access in 60%

 

Comparator:

  • Administration of equitable volume of normal saline

 

Outcome:

  • Primary outcome: Sustained ROSC for at least 20 minutes
    • 19% in calcium group vs 27% in placebo group
    • Risk ratio: 0.72 [95% CI, 0.49 to 1.03]
  • Secondary outcome
    • Survival at 30 days: 5.2% vs. 9.1%, RR 0.57 (95% CI -9.4 to 1.3)
    • Favorable neurologic outcome at 30 days: 3.6% vs. 7.6%, RR 0.48 (95% CI 0.20 to 1.12)
    • Hypercalcemia: Calcium group 74%, NS group 2%
  • Trial stopped early due to suggested harm in the calcium group

 

Take away:

  • Trial stopped early due to suggested harm
  • The trial asks a clinically important question, but it uses a surrogate outcome (ROSC for at least 20 minutes). Patient centered outcomes were secondary.
  • The study was stopped early which can overestimate harms. This also increases the risk that the results are due to random chance.
  • Overall this was a well conducted study, with no loss to follow up rate and few protocol deviations.
  • Authors did demonstrate that calcium administration increased calcium levels.
  • It took about 18 minutes to administer the study drug. It is possible calcium may be helpful if given early, but in all comers with OHCA, calcium is not warranted.
  • Few patients had shockable rhythms initially.
  • Hyperkalemia patients may receive the most benefit from calcium, but these patients were not included.

 

My take:

In all-comers with OHCA I won’t be giving calcium based on this trial. However, in trauma patients and those in whom I suspect hyperkalemia, calcium channel blocker overdose, or hypocalcemia, I absolutely will.

 

Reference:

  1. Vallentin MF, Granfeldt A, Meilandt C, et al. Effect of Intravenous or Intraosseous Calcium vs Saline on Return of Spontaneous Circulation in Adults With Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial. JAMA. 2021;326(22):2268-2276. doi:10.1001/jama.2021.20929

Share This:

Leave a Comment

Your email address will not be published. Required fields are marked *

emDOCs subscribes to the Free Open Access Meducation (FOAMed) initiative. Our goal is to inform the global EM community with timely and high-yield content about what providers like YOU are seeing and doing daily in your local ED.

WRITE FOR EMDOCS

We are actively recruiting both new topics and authors.
This project is rolling and you can submit an idea or write-up anytime!
Contact us at editors@emdocs.net

news, headlines, newsletter

Join our Newsletter

Keep up to date on all of the latest new articles, studies, and Podcasts.
Both tea tree oil and oil of oregano are toxic when ingested, so never drink them or mix with food. Solution prime ltd. Find millions of products across eu.